Genetic News and Research

RSS

CAP commends SACGHS stand against human health-related gene patents

The College of American Pathologists today expressed its support for a key government advisory group's recommendation to create an exemption from liability for infringement of gene patent claims when used for patient care purposes.

24 Oct 2009

Bioethicist honored with March of Dimes Distinguished Lectureship in Perinatal Bioethics award

A bioethicist who specializes in moral dilemmas families face when making medical decisions for critically-ill newborns was honored with the first-ever March of Dimes Distinguished Lectureship in Perinatal Bioethics.

24 Oct 2009

John Muir Health earns Network Cancer Program accreditation

John Muir Health’s Walnut Creek and Concord campuses have earned a three-year accreditation with commendation as a Network Cancer Program (NCP) from the American College of Surgeons Commission on Cancer (CoC), a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients. John Muir Health is one of only two hospitals in California and the only one in the San Francisco Bay Area to receive the recognition.

24 Oct 2009

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Medco Health Solutions, Inc.(NYSE: MHS) and the American Medical Association (AMA) today announced the findings of a national benchmark survey on physicians' acceptance, use and education regarding pharmacogenomic testing.

23 Oct 2009

Modified NAGA: New enzyme for enzyme replacement therapy

A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.

23 Oct 2009

Follow healthy lifestyle to overturn genetic predisposition to heart disease

When it comes to heart disease, lifestyle usually trumps genetics, says noted genetic researcher Dr. Robert Hegele, Heart and Stroke Foundation of Canada Lecturer at the Canadian Cardiovascular Congress 2009.

23 Oct 2009

New technique developed to transform regular body cells into artificial stem cells

Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in STEM CELLS, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.

23 Oct 2009

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, announced today it will extend the capabilities of its Sequence Enrichment Solution by offering Methyl-Seq and Ultra-Deep Resequencing applications.

23 Oct 2009

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

The Side-Out Foundation and its Dig Pink- Volleyball Breast Cancer Awareness campaign will launch a first of its kind clinical trial this month to examine the effects of individualized treatment on patients with metastatic breast cancer.

23 Oct 2009

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with Repligen Corporation for the development of a potential treatment of Spinal Muscular Atrophy (SMA).

23 Oct 2009

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.

23 Oct 2009

Intellectual property covering compounds that have utility in treating SMA licensed

Repligen Corporation announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy (FSMA) for intellectual property covering compounds which may have utility in treating Spinal Muscular Atrophy (SMA).

23 Oct 2009

NNu Skin Enterprises signs research agreements to develop next-generation skin care and nutritional products

Nu Skin Enterprises, Inc. today announced that it has entered into research agreements with Stanford University and LifeGen Technologies, a genomics company based in Madison, Wis. LifeGen co-founders, Richard Weindruch, Ph.D., and Tomas Prolla, Ph.D., will also hold positions on the newly formed Nu Skin Anti-aging Scientific Advisory Board.

23 Oct 2009

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Applied Biosystems, part of Life Technologies Corporation, today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use.

22 Oct 2009

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics’ three currently available diagnostic tests.

22 Oct 2009

Progenika to provide blood group genotyping reference laboratory services to ARUP

Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations.

22 Oct 2009

Drugs affecting the central nervous system effective against fibromyalgia, study finds

People suffering from fibromyalgia have reduced activity in the parts of the brain that inhibit the experience of pain. Drugs that affect the CNS can be effective against the disease, and are thought to be even more so if administered early in its course. This according to a new thesis from the Swedish medical university Karolinska Institutet.

22 Oct 2009

LANL and international researchers propose new genome sequence strategies

A team of geneticists at Los Alamos National Laboratory, together with a consortium of international researchers, has recently proposed a set of standards designed to elucidate the quality of publicly available genetic sequencing information.

22 Oct 2009

SAEC to collaborate with HMORN to improve the safe use of drugs

The International Serious Adverse Events Consortium (SAEC) announced today it will collaborate with the HMO Research Network (HMORN) to improve the safe use of drugs by exploring why the genetic makeup of some individuals makes them more likely to experience serious drug-related adverse events (SAEs).

22 Oct 2009

Research in specific cells and circuitry affected by addiction may help guard against relapse

New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.

22 Oct 2009

Genetic News and Research

CAP commends SACGHS stand against human health-related gene patents

Bioethicist honored with March of Dimes Distinguished Lectureship in Perinatal Bioethics award

John Muir Health earns Network Cancer Program accreditation

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Modified NAGA: New enzyme for enzyme replacement therapy

Follow healthy lifestyle to overturn genetic predisposition to heart disease

New technique developed to transform regular body cells into artificial stem cells

Methyl-Seq and Ultra-Deep Resequencing applications from RainDance Technologies

Dig Pink Volleyball Breast Cancer Awareness campaign to raise $1 million in support of breast cancer research

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Intellectual property covering compounds that have utility in treating SMA licensed

NNu Skin Enterprises signs research agreements to develop next-generation skin care and nutritional products

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Rosetta Genomics, GTG sign exclusive distribution agreement

Progenika to provide blood group genotyping reference laboratory services to ARUP

Drugs affecting the central nervous system effective against fibromyalgia, study finds

LANL and international researchers propose new genome sequence strategies

SAEC to collaborate with HMORN to improve the safe use of drugs

Research in specific cells and circuitry affected by addiction may help guard against relapse

Sequencing & Genomics: Elevating Science and Healthcare eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News